Venous Thromboembolism Risk (VTE) Risk after COVID-19 Vaccination
Research type
Research Study
Full title
Venous thromboembolism risk in covid vaccinated hip fracture patients
IRAS ID
316432
Contact name
Tosan Okoro
Contact email
Sponsor organisation
The Shrewsbury and Telford Hospital NHS Trust
Duration of Study in the UK
0 years, 2 months, 18 days
Research summary
As there seems to be an increased risk of blood clots in the legs and lungs in patients who have received vaccination for COVID-19, and the established risk of blood clots in patients who sustain hip fractures, the study is aimed at determining if there is a significant increase in the incidence of blood clots in patients who have received at least 2 doses of the COVID-19 vaccine and who at the same time sustain a hip fracture for which they had surgery.
REC name
South Central - Oxford A Research Ethics Committee
REC reference
22/SC/0281
Date of REC Opinion
16 Aug 2022
REC opinion
Favourable Opinion